WallStreetZenWallStreetZen

NASDAQ: TRIB
Trinity Biotech PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their TRIB stock forecasts and price targets.

Forecast return on equity

Is TRIB forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is TRIB forecast to generate an efficient return on assets?

Company
-5.93%
Industry
8.53%
TRIB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TRIB earnings per share forecast

What is TRIB's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.50

TRIB revenue forecast

What is TRIB's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$79.1M+80.54%

TRIB vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
TRIB$10.78N/AN/A
VNRX$0.80$28.00+3,422.01%Strong Buy
NDRA$4.54$25.00+450.66%Buy
XWEL$1.00N/AN/A
MBAI$1.30N/AN/A
View Top Diagnostic & Research Stocks

Trinity Biotech Stock Forecast FAQ

What is TRIB's earnings growth forecast for 2026-2026?

(NASDAQ: TRIB) Trinity Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Trinity Biotech's earnings in 2026 is -$37,376,000.

In 2026, TRIB is forecast to generate -$6,234,283 in earnings, with the lowest earnings forecast at -$5,989,801 and the highest earnings forecast at -$6,417,644.

If you're new to stock investing, here's how to buy Trinity Biotech stock.

What is TRIB's revenue growth forecast for 2026-2026?

(NASDAQ: TRIB) Trinity Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Trinity Biotech's revenue in 2026 is $43,785,000.

In 2026, TRIB is forecast to generate $986,034,523 in revenue, with the lowest revenue forecast at $947,366,502 and the highest revenue forecast at $1,015,035,538.

What is TRIB's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: TRIB) forecast ROA is -5.93%, which is lower than the forecast US Diagnostics & Research industry average of 8.53%.

What is TRIB's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: TRIB) Trinity Biotech's current Earnings Per Share (EPS) is -$60.00. In 2026, TRIB's EPS is forecast to hit -$0.50 (min: -$0.48, max: -$0.51).

What is TRIB's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: TRIB) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.